10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $726,309 | -25.0% | 17,608 | +1.5% | 0.00% | -33.3% |
| Q2 2023 | $968,910 | +101462.9% | 17,351 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $954 | +43.2% | 17,139 | -6.2% | 0.00% | +50.0% |
| Q4 2022 | $666 | -99.8% | 18,264 | +28.2% | 0.00% | 0.0% |
| Q3 2022 | $406,000 | -31.1% | 14,245 | +9.5% | 0.00% | 0.0% |
| Q2 2022 | $589,000 | -66.4% | 13,006 | +10.6% | 0.00% | -71.4% |
| Q4 2021 | $1,751,000 | -15.5% | 11,758 | -17.4% | 0.01% | -36.4% |
| Q3 2021 | $2,073,000 | -30.2% | 14,243 | -6.1% | 0.01% | -38.9% |
| Q2 2021 | $2,970,000 | – | 15,167 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |